Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings

Diabetes Care

Volumn 20, Issue 10, 1997, Pages 1547-1552

  Vandewalle, Christina L ^a   Falorni, Alberto ^c   Lernmark, Åke ^d   Goubert, Patrick ^a   Dorchy, Harry ^e   Coucke, Willy ^f,g   Semakula, Crispin ^a   Van Der Auwera, Bart ^a   Kaufman, Leon ^b   Schuit, Frans C ^a   Pipeleers, Daniël G ^a   Gorus, Frans K ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF WASHINGTON   (United States)

^e HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^f Heilig Hart Ziekenhuis   (Belgium)

^g Belgian Diabetes Registry   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; INSULIN ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENETIC MARKER; GENETIC RISK; HAPLOTYPE; HETEROZYGOTE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; ONSET AGE; PREVALENCE; SIBLING;

EID: 0030770285     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.10.1547     Document Type: Article

References (38)

1. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
2. Krolewski AS, Warram JH, Rand LI, Kahn CR: Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987
3. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo H, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/ IA-2 autoantibodies. Diabetes 45:926-933, 1996
4. Atkinson MA, Maclaren NK: Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 92:1608-1616, 1993
5. Bingley P, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
6. Bottazzo GF: On the honey disease: a dialogue with Socrates (Banting Lecture). Diabetes 42:778-800, 1993
7. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 93: 2307-2311, 1996
8. Vandewalle CL, Falorni A, Svanholm S, Lernmark Å, Pipeleers D, Gorus FK, the Belgian Diabetes Registry: High diagnostic sensitivity of glutamate decarboxylase autoantibodies in IDDM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 80:846-851, 1995
9. Zimmet PZ: The pathogenesis and prevention of diabetes in adults. Diabetes Care 18:1050-1064, 1995
10. Caillat-Zucman S, Garchon H-J, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougnères P, Bach J-F: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
11. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA-DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes before age 10 years but not at onset between age 10 and 40 years. Diabetologia 36:1155-1162, 1993
12. Blohmé G, Nyström L, Amqvist HJ, Lithner F, Littorin B, Olsson PO, Schertén B, Wibell L, Östman J: Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden. Diabetologia 35:56-62, 1992
13. Landin-Olsson M, Karlsson FA, Lemmark Å, Sundkvist G, the Diabetes Incidence Study in Sweden Group: Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-year-old patients in the Diabetes Incidence Study in Sweden. Diabetes 41:1022-1027, 1992
14. Van der Auwera B, Schuit F, Lyaruu I, Falorni A, Svanholm S, Vandewalle CL, Gorus FK, the Belgian Diabetes Registry: Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ and insulin gene-linked risk. J Clin Endocrinol Metab 80:2567-2573, 1995
15. Green A, Gale EAM, Patterson CC for the EURODIAB ACE Group: Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet 339:905-909, 1992
16. LaPorte RE, Tajima N, Åkerblom HK, Berlin N, Brosseau J, Christy M, Drash AL, Fishbein H, Green A, Hamman R, Harris M, King H, Laron Z, Neil A: Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care 8 (Suppl. 1):101-107, 1985
17. Heimberg H, Nagy ZP, Somers G, De Leeuw I, Schuit F: Complementation of HLA-DQA and DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 33:10-17, 1992
18. Gorus FK, Goubert PG, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG, the Belgian Diabetes Registry: IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
19. Pipeleers D, Zhidong L: Pancreatic beta-cells in insulin-dependent diabetes mellitus. Diabetes Metab Rev 8:209-227, 1992
20. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
21. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years: comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. Diabetes Care 20:1556-1561, 1997
22. Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG, the Belgian Diabetes Registry: Influence of age on the associations among insulin autoantibodies, islet cell antibodies and DQA1*0301-DQB1*0302 haplotype in siblings of IDDM patients. J Clin Endocrinol Metab 78:1172-1178, 1994
23. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577, 1993
24. Bodmer JG, Marsh SGE, Albert ED, Bodmer WE, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1995. Hum Immunol 43:149-164, 1995
25. Bland JM, Altman DG: Multiple significance tests: the Bonferroni method. BMJ 310:170, 1995
26. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark Å: Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
27. Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Åkerblom HK, Knip M: Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 81:2455-2459, 1996
28. Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39:1223-1226, 1996
29. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lemmark Å: Quantitation assay using recombinant human islet glutamic acid decarboxylase (GAD65-Ab) shows that 64k autoantibody positivity at onset predicts diabetes. J Clin Invest 91:368-374, 1993
30. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IA: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
31. Rowley MJ, Mackay IR, Chen QY, Knowles W, Zimmet P: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41:548-561, 1992
32. Aanstoot HJ, Sigurdsson E, Jaffe M, Shi Y, Christgau S, Grobbee D, Bruining GJ, Molenaar JL, Hofman A, Baekkeskov S: Value of antibodies to GAD65 combined with islet cell cytoplasmatic antibodies for predicting IDDM in a childhood population. Diabetologia 37:917-924, 1994
33. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stengård J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1994
34. Serjeantson SW, Court J, Mackay IR, Matheson B, Rowley MJ, Tuomi T, Wilson JD, Zimmet P: HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. Hum Immunol 38:97-104, 1993
35. Leslie RDG, Elliot RB: Early environmental events as a cause of IDDM. Diabetes 43: 843-650, 1994
36. Velloso LA, Björk E, Ballagi AE, Funa K, Andersson A, Kämpe O, Karlsson FA, Eizirik DL: Regulation of GAD expression in islets of Langerhans occurs both at the mRNA and protein level. Mol Cell Endocrinol 102:31-37, 1994
37. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus 1 modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet 15:289-292, 1997
38. Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth G, Benett ST, Patel DD: The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet 15:293-297, 1997